← FDA Drug Approvals (Drugs@FDA)
NEORAL
NDA · New Drug Application · Sponsor: NOVARTIS · Approved 1995-07-14
Drug application
- FDA Application #
NDA050715- Application type
- New Drug Application
- Brand name
- NEORAL
- Generic name
- CYCLOSPORINE
- Active ingredients
- CYCLOSPORINE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- NOVARTIS
- Manufacturer
- Novartis Pharmaceuticals Corporation
- First approval
- 1995-07-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown